News from receptos inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 04, 2013, 18:00 ET

Receptos Files Registration Statement for Proposed Initial Public Offering

Receptos, Inc., a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced...

Mar 13, 2013, 08:00 ET

Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease

 Receptos Inc. announced today that it has entered a Development License and Option Agreement to in-license a humanized anti-interleukin-13...

Mar 07, 2013, 05:00 ET

Receptos Determines Novel GPCR Structure, Achieves Key Milestone in Collaboration with Ono Pharmaceuticals

Receptos, a biopharmaceutical company focused on developing therapeutic candidates directed to G-protein-coupled receptor (GPCR) targets, announced...

Feb 14, 2013, 08:00 ET

Graham Cooper Appointed Chief Financial Officer of Receptos

Receptos, Inc. announced today that Graham Cooper has been appointed Chief Financial Officer. Mr. Cooper joins the company after serving as Chief...

Jan 04, 2013, 08:00 ET

Receptos Doses First Patient in Phase 2 Trial for RPC1063 in Ulcerative Colitis

 Receptos, Inc., announced today that its selective sphingosine‐1‐ phosphate 1 receptor (S1P1R) modulator, RPC1063, has been...

Oct 22, 2012, 08:00 ET

Receptos Doses First Patient in Phase 2/3 Trial for RPC1063 in Multiple Sclerosis

 Receptos, Inc., announced today that its selective sphingosine‐1‐ phosphate receptor 1 (S1P1) modulator, RPC1063, has been...

Oct 09, 2012, 08:00 ET

Receptos to Deliver Scientific Presentations about RPC1063 at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

 Receptos Inc. today announced that company personnel will deliver two scientific poster presentations about RPC1063 at the Congress of the...

Oct 01, 2012, 06:00 ET

Receptos to Present at the 10th Annual Discovery on Target Conference

Receptos Inc. today announced that the company is scheduled to present the Featured Presentation at the 10th Annual Discovery on Target Conference...

Aug 13, 2012, 12:30 ET

Receptos to Present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference

 Receptos Inc. today announced that the company is scheduled to present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference...

Jul 12, 2012, 15:11 ET

Receptos Co-Publishes Highest Resolution G-Protein Coupled Receptor Structure to Date in Science

Receptos Inc. announced today the co-publication, in conjunction with the Stevens Lab at The Scripps Research Institute®, of key results...

May 18, 2012, 08:00 ET

Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease

 Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week...

Mar 01, 2012, 08:00 ET

Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference

 Receptos Inc. today announced that the company is scheduled to present at the Cowen and Company 32nd Annual Health Care Conference at noon EST...

Feb 16, 2012, 14:48 ET

Receptos Scientists Publish Determination of a High Resolution Sphingosine 1-Phosphate Receptor 1 Structure in Science

 Receptos Inc. announced today the publication of key results relating to its expertise in S1P1 biology and structure-based drug...

Jan 10, 2012, 08:00 ET

Receptos Achieves Milestone Under License of G-Protein Coupled Receptor Crystal Structure Determination Technology

 Receptos Inc. today announced the successful achievement of the technology transfer milestone under its license and technology transfer deal...

Dec 12, 2011, 20:00 ET

Receptos and Ono Establish Collaboration with Focus on Bioactive Lipid Discovery Research

 Receptos Inc. announced today the establishment of a collaboration with Ono Pharmaceutical Co., Ltd. (Osaka, Japan) for the...